Physician profile
Alison Hause
NPI 1851002448
$1,181.08
in general payments reported to CMS, 2019-2025
11 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $379 · 2024: $681 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $601.21 | 2023-2025 | Nuplazid |
| Myriad Genetic Laboratories, INC. | $123.32 | 2023-2024 | Myrisk |
| Abbvie INC. | $118.51 | 2024 | |
| Ethicon US, LLC | $96.40 | 2023-2024 | Echelon Circular, Ethicon, Echelon; Endopath |
| Takeda Pharmaceuticals U.S.A., INC. | $71.02 | 2023-2025 | Gattex |
| Medtronic, INC. | $51.50 | 2024 | Interstim |
| Stryker Corporation | $40.99 | 2023 | Spy-Phi System |
| Heron Therapeutics, INC. | $28.99 | 2024 | Zynrelef |
| La Jolla Pharmaceutical Company | $19.16 | 2023 | Xerava |
| Coloplast Corp | $16.35 | 2024 | |
| Pacira Pharmaceuticals Incorporated | $13.63 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alison Hause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.